Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
International Journal of Pharmaceutics|October 19, 2006
Computational prediction of solubilizers' effect on partitioningJan Hoest, Inge T Christensen, Flemming S Jørgensen, et al.Bioorganic & Medicinal Chemistry|December 28, 2005
New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore designLars Olsen, Sandra Jost, Hans-Werner Adolph, et al.Journal of Natural Products|May 29, 2004
Isolation of a library of aromadendranes from Landolphia dulcis and its characterization using the VolSurf approachDan Staerk, Brian Skole, Flemming S Jørgensen, et al.Journal of Structural Biology|February 10, 2007
Study on the binding of Thioflavin T to beta-sheet-rich and non-beta-sheet cavitiesMinna Groenning, Lars Olsen, Marco van de Weert, et al.The Journal of Biological Chemistry|October 21, 2015
Salt Bridge Swapping in the EXXERFXYY Motif of Proton-coupled Oligopeptide TransportersNanda G Aduri, Bala K Prabhala, Heidi A Ernst, et al.Human Mutation|July 19, 2002
Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic diseaseBent N Terp, David N Cooper, Inge T Christensen, et al.Biopolymers|March 13, 2010
A diversity optimized combinatorial library for the identification of Fc-fragment binding ligandsAnders L Nielsen, Flemming S Jørgensen, Lars Olsen, et al.Blood|December 13, 2005
Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemiaAnne Mette Buhl, Jesper Jurlander, Flemming S Jørgensen, et al.The Journal of Biological Chemistry|November 7, 2009
Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporterJacob Andersen, Lars Olsen, Kasper B Hansen, et al.Journal of Medicinal Chemistry|December 30, 2003
Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullonesConrad Kunick, Kathrin Lauenroth, Karen Wieking, et al.Pageof 2